The estimated Net Worth of Craig A. Barbarosh is at least $2.75 million dollars as of 1 September 2022. Mr. Barbarosh owns over 3,500 units of NextGen Healthcare Inc stock worth over $1,368,961 and over the last 14 years he sold NXGN stock worth over $998,070. In addition, he makes $379,002 as Independent Vice Chairman of the Board at NextGen Healthcare Inc.
Craig has made over 14 trades of the NextGen Healthcare Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he sold 3,500 units of NXGN stock worth $60,445 on 1 September 2022.
The largest trade he's ever made was selling 9,000 units of NextGen Healthcare Inc stock on 2 November 2021 worth over $148,860. On average, Craig trades about 324 units every 22 days since 2010. As of 1 September 2022 he still owns at least 57,183 units of NextGen Healthcare Inc stock.
You can see the complete history of Mr. Barbarosh stock trades at the bottom of the page.
Craig A. Barbarosh J.D., Esq. serves as Independent Vice Chairman of the Board of the Company. He is a director and has served as our Vice Chairman of the Board since November 2015. Mr. Barbarosh is also a director of Sabra Health Care REIT, Inc. (Nasdaq: SBRA) where he is the Chair of the Audit Committee and a member of the Compensation Committee, and a director of Landec Corporation (Nasdaq: LNDC), where he is a member of the Compensation Committee. Mr. Barbarosh previously served on the boards of Aratana Therapeutics, Inc. (Nasdaq: PETX), where he was a member of the Compensation Committee and Chair of the Strategic Review Committee, BioPharmX, Inc., (NYSE: BPMX), where he was the Chair of the Nominating and Governance Committee and a member of the Audit and Compensation Committees, and Bazaarvoice, Inc. (NYSE MKT: BPMX), where he was a member of the Compensation Committee. Mr. Barbarosh also served as the independent board observer for Payless Holdings, LLC during its Chapter 11 proceeding. Mr. Barbarosh is a partner at the international law firm of Katten Muchin Rosenman LLP, a position he has held since June 2012. Previously, Mr. Barbarosh was a partner of the international law firm of Pillsbury Winthrop Shaw Pittman LLP. Mr. Barbarosh is a nationally recognized restructuring expert who, during the nearly three decades of his legal career, has represented lenders, indenture trustees and bondholders and other investors and their agents in some of the largest corporate restructuring cases in the country. He served in several leadership positions while a partner at Pillsbury including serving on the firm’s Managing Board, as the Chair of the firm’s Board’s Strategy Committee, as a co-leader of the firm’s national Insolvency & Restructuring practice section and as the Managing Partner of the firm’s Orange County office.
As the Independent Vice Chairman of the Board of NextGen Healthcare Inc, the total compensation of Craig Barbarosh at NextGen Healthcare Inc is $379,002. There are 9 executives at NextGen Healthcare Inc getting paid more, with John Frantz having the highest compensation of $6,306,870.
Craig Barbarosh is 53, he's been the Independent Vice Chairman of the Board of NextGen Healthcare Inc since 2015. There are 15 older and 2 younger executives at NextGen Healthcare Inc. The oldest executive at NextGen Healthcare Inc is Sheldon Razin, 82, who is the Chairman Emeritus and Independent Director.
Craig's mailing address filed with the SEC is C/O SABRA HEALTH CARE REIT, INC., 1781 FLIGHT WAY, TUSTIN, CA, 92782.
Over the last 6 years, insiders at NextGen Healthcare Inc have traded over $7,074,219 worth of NextGen Healthcare Inc stock and bought 30,075 units worth $371,046 . The most active insiders traders include David William Sides, Lance Rosenzweig et David A Metcalfe. On average, NextGen Healthcare Inc executives and independent directors trade stock every 28 days with the average trade being worth of $352,900. The most recent stock trade was executed by Mitchell Waters on 22 September 2023, trading 5,452 units of NXGN stock currently worth $130,521.
nextgen healthcare information systems, llc, a wholly owned subsidiary of quality systems, inc., provides integrated clinical, financial, and connectivity solutions for primary care physicians, specialist physicians, health systems, and dental provider organizations. the company drives collaborative care and patient engagement with a comprehensive suite of products and services that support emerging initiatives such as patient-centered medical home, accountable care organizations, and health information exchange.
NextGen Healthcare Inc executives and other stock owners filed with the SEC include: